3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hepatitis B
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
entecavir
7
Lamivudine
3
Tenofovir
2
peginterferon alfa-2b
1
lenvatinib
1
bicyclol
1
adefovir
1
Urinalysis
1
Ultrasonography
1
Tumor Necrosis Factor-alpha
1
Telbivudine
1
Tablets
1
Rapid Diagnostic Tests
1
Radiomics
1
Radiofrequency Ablation
1
Polymorphism, Genetic
1
Pharmaceutical Preparations
1
Nucleosides
1
Nivolumab
1
Interferons
1
Hypothermia, Induced
1
Hepatitis B Vaccines
1
Enzyme-Linked Immunosorbent Assay
1
Cyclophosphamide
1
Control Groups
1
Cognitive Behavioral Therapy
1
Cholecalciferol
1
Acids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hepatitis B
×
Telbivudine
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled